首页> 外文期刊>Oncology letters >MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1
【24h】

MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1

机译:MicroRNA-133B通过靶向FSCN1抑制非小细胞肺癌细胞的迁移和侵袭

获取原文
获取原文并翻译 | 示例

摘要

MicroRNA (miR)-133b has been reported to act as a tumor suppressor in multiple types of human cancers, including non small cell lung cancer (NSCLC). However, the underlying mechanism by which miR-133b inhibits NSCLC metastasis remains largely unclear. In the present study, reverse transcription-quantitative polymerase chain reaction and western blotting were used to detect messenger RNA and protein expression. A wound healing assay and transwell assay were used to examine the cell migration and invasion. The expression level of miR-133b was found to be significantly downregulated in NSCLC cell lines compared with normal lung epithelial BEAS-2B cells. Further investigation identified fascin1 (FSCN1) as a direct target of miR-133b in NSCLC cells. The expression of FSCN1 was significantly increased in NSCLC cell lines compared with BEAS-2B cells, and its protein expression was negatively regulated by miR-133b in NSCLC A549 cells. Further investigation showed that the upregulation of miR-133b notably inhibited NSCLC cell migration and invasion, while the overexpression of FSCN1 significantly promoted NSCLC cell migration and invasion. Furthermore, the overexpression of FSCN1 reversed the suppressive effect of miR-133b overexpression on NSCLC cell migration and invasion. Accordingly, the present study suggests that miR-133b inhibits the migration and invasion of NSCLC cells via directly targeting FSCN1, and thus may be used for the treatment of NSCLC metastasis.
机译:据报道,MicroRNA(miR)-133b作为多种人类癌症中的肿瘤抑制剂,包括非小细胞肺癌(NSCLC)。然而,miR-133b抑制nsclc转移的潜在机制仍然很目的不清楚。在本研究中,使用逆转录定量聚合酶链反应和蛋白质印迹来检测信使RNA和蛋白质表达。伤口愈合测定和Transwell测定用于检查细胞迁移和侵袭。与正常肺上皮BEA-2B细胞相比,发现MIR-133B的表达水平在NSCLC细胞系中显着下调。进一步调查将Fascin1(FSCN1)鉴定为NSCLC细胞中miR-133b的直接靶标。与BEA-2B细胞相比,NSCLC细胞系中FSCN1的表达显着增加,并且其蛋白质表达在NMSCLC A549细胞中通过miR-133b负调节。进一步的研究表明,MIR-133B的上调显着抑制了NSCLC细胞迁移和侵袭,而FSCN1的过表达显着促进了NSCLC细胞迁移和侵袭。此外,FSCN1的过表达逆转MIR-133B过表达对NSCLC细胞迁移和侵袭的抑制作用。因此,本研究表明,MIR-133B通过直接靶向FSCN1抑制NSCLC细胞的迁移和侵袭,因此可用于治疗NSCLC转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号